Scott C. Kachlany
Fondateur chez Actinobac Biomed, Inc.
Postes actifs de Scott C. Kachlany
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Fondateur | 17/07/2009 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2009 | - | |
| Directeur/Membre du Conseil | 01/01/2009 | - | |
| Corporate Officer/Principal | - | - | |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Scott C. Kachlany
Anciens postes connus de Scott C. Kachlany
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01/01/2003 | - |
Formation de Scott C. Kachlany
| Cornell University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Bourse
- Insiders
- Scott C. Kachlany
- Expérience
